# Nuclide record quirem-medical (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/quirem-medical/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "quirem-medical" ;
  schema:name "Quirem Medical"@en ;
  schema:alternateName "Quirem Medical B.V."@en ;
  schema:description "A Dutch company, owned by Terumo, that makes tiny radioactive beads containing holmium-166 which are injected into the liver's blood vessels to irradiate liver tumours from the inside, plus the imaging tools used to plan and check that treatment."@en ;
  schema:url <https://nuclide.cc/companies/quirem-medical/>, <https://www.quirem.com> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.terumo.com/newsrelease/detail/20200715/543>, <https://www.terumo.com/newsrelease/detail/20240703/6221>, <https://www.terumo.com/newsrelease/detail/20220614/5296>, <https://www.terumo.com/newsrelease/detail/20180412/274>, <https://www.quirem.com/wp-content/uploads/2022/10/LC-8007204-Administration-Procedure-Manual.pdf> ;
  nuclide:status "active" ;
  nuclide:tag "holmium-166", "radioembolisation", "liver cancer", "SIRT" ;
  schema:addressCountry "NL" ;
  nuclide:related <https://nuclide.cc/technologies/radioembolisation-tare/>, <https://nuclide.cc/indications/hcc/>, <https://nuclide.cc/indications/hcc-intermediate/>, <https://nuclide.cc/companies/sirtex/>, <https://nuclide.cc/companies/boston-scientific/>, <https://nuclide.cc/technologies/spect/>, <https://nuclide.cc/terms/tare/>, <https://nuclide.cc/isotopes/tc-99m/>, <https://nuclide.cc/isotopes/y-90/>, <https://nuclide.cc/isotopes/ho-166/> .
